YR001
/ Hangzhou Yirui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
November 26, 2025
Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=35 | Completed | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Recruiting ➔ Completed
Trial completion • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
March 25, 2025
Topical YR001 Ointment in Adult with Mild to Moderate Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=36 | Recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Trial completion date: Jun 2025 ➔ Dec 2025 | Trial primary completion date: Jan 2025 ➔ Dec 2025
Trial completion date • Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
June 26, 2024
Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=36 | Recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
March 13, 2024
Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=36 | Not yet recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd
New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
January 24, 2024
A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=54 | Completed | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Recruiting ➔ Completed
Trial completion • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Psoriasis
May 26, 2023
A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=54 | Recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Psoriasis
February 08, 2023
A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=54 | Not yet recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd
New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Psoriasis
1 to 7
Of
7
Go to page
1